HER2-positive breast cancer consists of four intrinsic molecular subtypes, luminal A, luminal B, basal-like, and HER2-enriched, with the last-one being the predominant subtype corresponding to about 60–70% of all HER2-positive breast cancers. Here, ERBB2 is linked to breast carcinoma.